Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally for Advanced Head and Neck Squamous Cell Carcinoma Article

sustainable development goals

publication date

  • April 1, 2022

webpage

published in

start page

  • 1345

end page

  • 1352

volume

  • 28

issue

  • 7